Alibaba Group Holding Ltd: Form 20-F for the period ended Mar 31, 2023
Filed with the SEC on Jul 21, 2023 and accepted by EDGAR at Jul 21, 2023, 11:43 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-04-01 to 2023-03-31 | $126.49bn | us-gaap:Revenues |
| Cost of revenue | 12 months2022-04-01 to 2023-03-31 | $80.04bn | us-gaap:CostOfRevenue |
| Research and development | 12 months2022-04-01 to 2023-03-31 | $8.26bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2022-04-01 to 2023-03-31 | $14.61bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-04-01 to 2023-03-31 | $862.0m | us-gaap:InterestExpense |
| Income tax | 12 months2022-04-01 to 2023-03-31 | $2.26bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-04-01 to 2023-03-31 | $10.60bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-04-01 to 2023-03-31 | $0.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-04-01 to 2023-03-31 | $0.50 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-04-01 to 2023-03-31 | 21,114,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-04-01 to 2023-03-31 | $29.09bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 12 months2022-04-01 to 2023-03-31 | $10.88bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-03-31 | $28.11bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $101.63bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $255.26bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $56.11bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $91.75bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-03-31 | $144.10bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-03-31 | 20,526,017,712 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-23-033752. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.